Arogo Capital Acquisition Corp. (Nasdaq: AOGO) is a blank-check special purpose acquisition company sponsored by Arogo Capital LLC. The company completed its initial public offering in 2022 and has targeted the healthcare and technology sectors in its search for a business combination. In May 2026, Arogo filed a preliminary proxy statement amendment (Form PRER14A) with the SEC, accession number 0001213900-26-060271, indicating active shareholder engagement as the company navigates its deal timeline. The filing reflects ongoing corporate proceedings typical of SPACs in the later stages of their search-and-approval cycle. Investors and researchers seeking complete financials, extension history, and deal status for AOGO can access full data by signing up at SpacDesk.